NCT02219126

Brief Summary

This study aims to investigate differences in digestion rates and stomach problems caused by pasteurized and homogenized milk compared with raw milk in healthy adults by ingestible capsule that measures pH and pressure, diary of symptoms, blood glucose and triacylglycerol levels and plasma cytokine levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

January 16, 2018

Status Verified

January 1, 2018

Enrollment Period

1.6 years

First QC Date

August 14, 2014

Last Update Submit

January 12, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pressure in the intestinal tract

    Pressure in the intestinal tract as measured by ingestible Smart Pill -capsule.

    Day 0 - Day 5

  • Gastrointestinal symptoms (self-reported)

    Gastrointestinal symptoms (self-reported) as measured by a questionnaire. The questionnaire is devided into seven types of stomach discomfort, and also includes a possibility to describe a stomach discomfort outside these seven given alternatives. The severity of the symptoms is self-reported on a three-step scale.

    Day 0 - Day 5

Secondary Outcomes (4)

  • Plasma triacylglycerols

    20min, 40min, 60min, 120min, 180min, 240min

  • Plasma glucose

    20min, 40min, 60min, 90min, 120min, 180min, 240min

  • Plasma triacylglycerols

    20min, 40min, 60min, 90min, 120min, 180min, 240min

  • Plasma insulin

    20min, 40min, 60min, 90min, 120min, 180min, 240min

Study Arms (2)

Homogenized and pasteurized milk

EXPERIMENTAL

Milk that has undergone homogenization ans pasteurization treatment

Other: Dietary intervention

Nonhomogenized and nonpasteurized milk

EXPERIMENTAL

Unhomogenized and unpasteurized milk (raw milk)

Other: Dietary intervention

Interventions

Homogenized and pasteurized milkNonhomogenized and nonpasteurized milk

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Homogenized and pasteurized milk causes stomach problems (self-reported)
  • unhomogenized and unpasteurized milk does not cause stomach problems (self-reported)
  • age 18-65
  • BMI 18,5 - 30
  • hemoglobin under normal range
  • fasting plasma alanine aminotransferase ALAT \< 60 U/l (normal liver function)
  • fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function)
  • fasting plasma creatinine \< 118 umol/l (normal kidney function)

You may not qualify if:

  • pace maker
  • Crohn's disease or other disease of the intestinal tract
  • intestinal operation within the last 3 months
  • difficult dysphagia
  • smoking
  • constipation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Biochemistry University of Turku

Turku, 20014, Finland

Location

MeSH Terms

Interventions

Diet Therapy

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Kaisa M Linderborg, PhD

    University of Turku

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Adjunct professor

Study Record Dates

First Submitted

August 14, 2014

First Posted

August 18, 2014

Study Start

August 1, 2014

Primary Completion

March 1, 2016

Study Completion

January 1, 2018

Last Updated

January 16, 2018

Record last verified: 2018-01

Locations